Balyasny Asset Management
NRIX icon

Balyasny Asset Management’s Nurix Therapeutics NRIX Stock Holding History

Balyasny Asset Management’s Portfolio NRIX Stock Details NRIX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$1.12M Buy
2024
Q1 		– Sell
2023
Q4 		$233K Sell
2023
Q3 		$207K Buy
2022
Q4 		– Sell
2022
Q3 		$208K Buy
2021
Q3 		– Sell
2021
Q2 		$2.08M Buy
2021
Q1 		$1.35M Buy